Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
JAZZ PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
1.33%20.9014.1%$122.98m
MDCOMedicines Company
0.36%52.1920.3%$105.31m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.49%116.216.2%$93.24m
AMRNAmarin Corporation Plc Sponsored ADR
1.51%15.451.8%$83.00m
JAZZJazz Pharmaceuticals Plc
-0.86%117.652.3%$55.11m
SAGESAGE Therapeutics, Inc.
-0.87%139.338.6%$53.47m
PRGOPerrigo Co. Plc
-0.67%53.086.8%$52.25m
PCRXPacira Pharmaceuticals, Inc.
-2.87%36.6110.5%$44.36m
UTHRUnited Therapeutics Corporation
-0.78%81.2514.3%$39.02m
CTLTCatalent Inc
-0.66%48.312.4%$34.63m
HZNPHorizon Pharma plc
0.81%27.286.6%$32.55m
ICLRICON Plc
-1.08%140.644.1%$32.29m
ICPTIntercept Pharmaceuticals, Inc.
2.15%60.8316.9%$30.53m
AERIAerie Pharmaceuticals, Inc.
-2.21%19.716.8%$27.29m
ENDPEndo International Plc
-9.31%3.368.8%$23.18m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.